Treace Medical Concepts Inc
Ouvert
4.41 0.92
Résumé
Variation du prix de l'action
24h
Min
4.3
Max
4.51
Revenu | 2.1M -16M |
|---|---|
Ventes | -1.8M 45M |
BPA | -0.24 |
Marge bénéficiaire | -34.981 |
Employés | 450 |
EBITDA | 3.1M -12M |
Prochains Résultats | 5 nov. 2026 |
|---|
Capitalisation Boursière | 9.2M 313M |
|---|---|
Ouverture précédente | 3.49 |
Clôture précédente | 4.41 |
Treace Medical Concepts Inc Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
Actualités Associées
Comparaison
Variation de prix
Treace Medical Concepts Inc prévision
Éléments financiers
Frais Généraux et Administratifs
Dépenses d'exploitation
Résultat avant impôt
Ventes
Coût des ventes
Marge brute des ventes
Charges d'intérêt sur la dette
EBITDA
Bénéfice d'exploitation
$
À Propos Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.